Biogen and City Therapeutics Announce Strategic Research
CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and City Therapeutics, Inc., a privately held biopharmaceutical...
Biogen
Biogen And Neomorph Announce Multi-Target Research Collaboration To Discover And Develop Molecular Glue Degraders For Alzheimer’S, Rare, And Immunological Diseases
Biogen And Neomorph Announce Multi-Target Research Collaboration To Discover And Develop Molecular Glue Degraders For Alzheimer’S, Rare, And Immunological...
Biogen and Neomorph Announce Multi-Target Research
The collaboration aims to discover and develop molecular glue degrader clinical candidates for priority targets to Biogen.Collaboration leverages Neomorph's leading...
